Headlands Technologies »

Adial Pharmaceuticals shares owned by Headlands Technologies

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $84 64 1.33

More positions owned by Headlands Technologies

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Linde SHS (LIN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vale S A Sponsored Ads (VALE)
Asml Holding N V N Y Registry Shs (ASML)
Rio Tinto Sponsored Adr (RIO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Applied Materials (AMAT)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Broadcom (AVGO)
At&t (T)
Verisign (VRSN)

View all positions for Headlands Technologies

Top funds holding Adial Pharmaceuticals

Manchester Capital Management
Hrt Financial
BlackRock
UBS Group
Tower Research Capital
Advisor Group Holdings
Headlands Technologies
Benjamin F. Edwards & Company
Royal Bank of Canada
Morgan Stanley
Wells Fargo & Company
Qube Research & Technologies

View all funds holding Adial Pharmaceuticals